Randomized Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies
Conditions: Dyslipidemias; Hypercholesterolemia; Familial Hypercholesterolemia; ASCVD; High Cholesterol Interventions: Combination Product: Combination Therapy; Drug: Monotherapy obicetrapib; Drug: Monotherapy ezetimibe; Other: Combination Therapy placebo; Other: Obicetrapib Placebo; Other: Ezetimibe Placebo Sponsor: NewAmsterdam Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies
Conditions: Dyslipidemias; Hypercholesterolemia; Familial Hypercholesterolemia; ASCVD; High Cholesterol Interventions: Combination Product: Combination Therapy; Drug: Monotherapy obicetrapib; Drug: Monotherapy ezetimibe; Other: Combination Therapy placebo; Other: Obicetrapib Placebo; Other: Ezetimibe Placebo Sponsor: NewAmsterdam Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials